• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分步血浆分离吸附系统:一种用于血液净化以去除与白蛋白结合物质的新型系统。

Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances.

作者信息

Falkenhagen D, Strobl W, Vogt G, Schrefl A, Linsberger I, Gerner F J, Schoenhofen M

机构信息

Center of Biomedical Technology, Danube University Krems, Austria.

出版信息

Artif Organs. 1999 Jan;23(1):81-6. doi: 10.1046/j.1525-1594.1999.06292.x.

DOI:10.1046/j.1525-1594.1999.06292.x
PMID:9950184
Abstract

The removal of albumin bound substances has gained increasing interest in different diseases, especially in acute and chronic liver disease. Therefore, a new system, the fractionated plasma separation and adsorption (FPSA) system, was developed based on combined membrane and adsorbent blood purification techniques. The most important contribution to the FPSA system was the development of a new polysulfone hollow-fiber filter, which is characterized by a sieving coefficient of 0.89 for human serum albumin (HSA) but only of 0.17 for fibrinogen, and 0 (zero) for IgM immunoglobulins. Using a closed filtrate circuit connected to the new polysulfone filter which integrates 1 or 2 adsorption columns and also a high flux dialyzer adapted to a dialysis machine, the FPSA system opens excellent possibilities for the relatively specific removal of albumin bound substances from the blood such as albumin bound bilirubin or even tryptophan. In comparison to other systems (for example, the Molecular Adsorbent Recirculating System [MARS] and albumin dialysis systems), the FPSA system enables much higher elimination of strongly bound albumin substances. The first clinical investigations have recently started based on a modified dialysis machine designed with all necessary safety measures.

摘要

去除与白蛋白结合的物质在不同疾病中越来越受到关注,尤其是在急慢性肝病中。因此,基于膜和吸附剂血液净化技术的结合,开发了一种新的系统——分级血浆分离吸附(FPSA)系统。对FPSA系统最重要的贡献是开发了一种新的聚砜中空纤维滤器,其对人血清白蛋白(HSA)的筛分系数为0.89,而对纤维蛋白原仅为0.17,对IgM免疫球蛋白为0(零)。通过使用连接到新聚砜滤器的封闭滤液回路,该回路集成了1个或2个吸附柱以及一个适用于透析机的高通量透析器,FPSA系统为从血液中相对特异性地去除与白蛋白结合的物质(如与白蛋白结合的胆红素甚至色氨酸)提供了极好的可能性。与其他系统(例如分子吸附循环系统 [MARS] 和白蛋白透析系统)相比,FPSA系统能够更高程度地清除与白蛋白紧密结合的物质。最近,基于配备了所有必要安全措施的改良透析机,首次开展了临床研究。

相似文献

1
Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances.分步血浆分离吸附系统:一种用于血液净化以去除与白蛋白结合物质的新型系统。
Artif Organs. 1999 Jan;23(1):81-6. doi: 10.1046/j.1525-1594.1999.06292.x.
2
An albumin-fixed membrane for the removal of protein-bound toxins.一种用于去除与蛋白质结合毒素的白蛋白固定膜。
Biomed Mater. 2006 Sep;1(3):170-4. doi: 10.1088/1748-6041/1/3/012. Epub 2006 Aug 25.
3
Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins.
Artif Organs. 1993 Sep;17(9):809-13. doi: 10.1111/j.1525-1594.1993.tb00635.x.
4
Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure.应用分子吸附再循环系统(MARS)治疗急性中毒伴或不伴有肝功能衰竭。
Clin Toxicol (Phila). 2011 Nov;49(9):782-93. doi: 10.3109/15563650.2011.624102.
5
[Extracorporeal blood purification in severe liver failure with the albumin dialysis MARS -- impact on relevant intensive care parameters].[采用白蛋白透析MARS进行体外血液净化治疗重度肝衰竭——对相关重症监护参数的影响]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2005 Apr;40(4):199-206. doi: 10.1055/s-2004-826116.
6
Comparison of the new polyethersulfone high-flux membrane DIAPES HF800 with conventional high-flux membranes during on-line haemodiafiltration.新型聚醚砜高通量膜DIAPES HF800与传统高通量膜在在线血液透析滤过过程中的比较。
Nephrol Dial Transplant. 2003 Nov;18(11):2382-6. doi: 10.1093/ndt/gfg410.
7
In vitro and in vivo evaluation of a new polysulfone membrane for hemodialysis. Reference methodology and clinical results. (Part. 2: in vivo study).
Int J Artif Organs. 1999 Sep;22(9):616-24.
8
Efficiency of post-dilution hemodiafiltration with a high-flux α-polysulfone dialyzer.使用高通量α-聚砜透析器进行后稀释血液透析滤过的效率
Int J Artif Organs. 2011 May;34(5):397-404. doi: 10.5301/IJAO.2011.8330.
9
Effects of Plasma Proteins on the Transport and Surface Characteristics of Polysulfone/Polyethersulfone and Asymmetric Cellulose Triacetate High Flux Dialyzers.血浆蛋白对聚砜/聚醚砜及不对称三醋酸纤维素高通量透析器转运和表面特性的影响。
Artif Organs. 2018 Nov;42(11):1070-1077. doi: 10.1111/aor.13154. Epub 2018 May 17.
10
[Efficiency of dialysis with albumin in the treatment of patients with advanced hepatic insufficiency: initial experience with the MARS system in Spain].[白蛋白透析治疗晚期肝功能不全患者的疗效:西班牙MARS系统的初步经验]
Nefrologia. 2001 Jul-Aug;21(4):376-85.

引用本文的文献

1
Extracorporeal therapies for post-liver transplant recipient: The road less traveled.肝移植受者的体外治疗:鲜有人走的路。
World J Transplant. 2025 Sep 18;15(3):101975. doi: 10.5500/wjt.v15.i3.101975.
2
Liver replacement therapy with extracorporeal blood purification techniques current knowledge and future directions.采用体外血液净化技术的肝脏替代疗法:当前认知与未来方向
World J Clin Cases. 2023 Jun 16;11(17):3932-3948. doi: 10.12998/wjcc.v11.i17.3932.
3
Extracorporeal liver support and liver transplantation for acute-on-chronic liver failure.
急性慢性肝衰竭的体外肝脏支持与肝移植
Liver Int. 2025 Mar;45(3):e15647. doi: 10.1111/liv.15647. Epub 2023 Jun 14.
4
COVID-19 and Extracorporeal Membrane Oxygenation.新型冠状病毒肺炎与体外膜肺氧合
Adv Exp Med Biol. 2021;1353:173-195. doi: 10.1007/978-3-030-85113-2_10.
5
The Roles of Membrane Technology in Artificial Organs: Current Challenges and Perspectives.膜技术在人工器官中的作用:当前挑战与展望
Membranes (Basel). 2021 Mar 28;11(4):239. doi: 10.3390/membranes11040239.
6
Additive treatment considerations in COVID-19-The clinician's perspective on extracorporeal adjunctive purification techniques.在 COVID-19 中的附加治疗考虑因素-临床医生对外科辅助净化技术的看法。
Artif Organs. 2020 Sep;44(9):918-925. doi: 10.1111/aor.13748. Epub 2020 Jul 7.
7
A Bifunctional Adsorber Particle for the Removal of Hydrophobic Uremic Toxins from Whole Blood of Renal Failure Patients.一种用于从肾衰竭患者全血中去除疏水性尿毒症毒素的双功能吸附颗粒。
Toxins (Basel). 2019 Jul 3;11(7):389. doi: 10.3390/toxins11070389.
8
An evaluation of the usefulness of extracorporeal liver support techniques in patients with severe liver dysfunction.对严重肝功能不全患者体外肝脏支持技术有效性的评估。
Arch Med Sci. 2019 Jan;15(1):99-112. doi: 10.5114/aoms.2017.67998. Epub 2017 May 25.
9
Artificial liver support systems: what is new over the last decade?人工肝支持系统:过去十年有哪些新进展?
Ann Intensive Care. 2018 Nov 15;8(1):109. doi: 10.1186/s13613-018-0453-z.
10
Acute kidney injury in children with chronic liver disease.儿童慢性肝脏疾病中的急性肾损伤。
Pediatr Nephrol. 2019 Jan;34(1):45-59. doi: 10.1007/s00467-018-3893-7. Epub 2018 Mar 1.